• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤缺氧与锝示踪剂:体内研究

Tumour hypoxia and technetium tracers: in vivo studies.

作者信息

Abrantes A M, Serra E, Goncalves C, Oliveiros B, Laranjo M, Sarmento-Ribeiro A B, Rocha-Gonsalves A, Botelho M F

机构信息

Biophysics/Biomatematics Institute, IBILI, Faculty of Medicine, University of Coimbra, Portugal.

出版信息

Curr Radiopharm. 2012 Apr;5(2):99-105. doi: 10.2174/1874471011205020099.

DOI:10.2174/1874471011205020099
PMID:22280110
Abstract

INTRODUCTION

Hypoxia is a biochemical condition where reduced oxygen partial pressure at tissue level occurs. This metabolic situation can lead to resistance to radio and chemotherapy. In malignant solid tumours, hypoxia is a common characteristic, having a great impact at biological level, being of tremendous importance for complete understanding of tumour progression.

OBJECTIVES

We studied the behavior of 99mTc-HL91 in vivo, using an animal model based on Balb-c nu/nu mice with a xenotransplant of the human colorectal adenocarcinoma cell line, WiDr.

MATERIAL AND METHODS

In vivo studies using an animal model of xenograft on Balb/c nu/nu nude mice were carried out. This model, allowed us to evaluate the radiopharmaceutical biodistribution and to calculate tumour/muscle ratio, acquired after 99mTc-HL91 injection. We also performed ex vivo studies, using the excised tumours to access viability and to characterize the intracellular production of reactive oxygen species and the status of mitochondrial membrane potential through flow cytometry.

RESULTS AND DISCUSSION

The biodistribution after 99mTc-HL91 injection showed urinary and hepatobilliary excretion in similar proportions and tumour uptake around 4.4% of administered activity. This uptake was higher at the bigger tumours. Through flow cytometry we observed that larger tumours have a higher amount of reactive oxygen species and a decrease in mitochondrial membrane potential.

CONCLUSIONS

99mTc-HL91 allowed a non-invasive evaluation of the solid tumours oxidative state by nuclear medicine functional imaging. This information can be of high importance at the pre-treatment estimation of this type of tumours.

摘要

引言

缺氧是一种在组织水平上氧分压降低的生化状态。这种代谢情况可导致对放疗和化疗产生抗性。在恶性实体瘤中,缺氧是一个常见特征,在生物学层面有重大影响,对于全面理解肿瘤进展极为重要。

目的

我们使用基于Balb-c nu/nu小鼠的动物模型,该模型移植了人结肠直肠腺癌细胞系WiDr,研究了99mTc-HL91在体内的行为。

材料与方法

在Balb/c nu/nu裸鼠异种移植动物模型上进行了体内研究。该模型使我们能够评估放射性药物的生物分布,并计算99mTc-HL91注射后获得的肿瘤/肌肉比值。我们还进行了体外研究,使用切除的肿瘤通过流式细胞术评估活力、表征细胞内活性氧的产生以及线粒体膜电位状态。

结果与讨论

99mTc-HL91注射后的生物分布显示,尿液和肝胆排泄比例相似,肿瘤摄取约为给药活性的4.4%。在较大肿瘤中这种摄取更高。通过流式细胞术我们观察到,较大肿瘤具有更高量的活性氧且线粒体膜电位降低。

结论

99mTc-HL91通过核医学功能成像实现了对实体瘤氧化状态的无创评估。该信息在这类肿瘤的治疗前评估中可能非常重要。

相似文献

1
Tumour hypoxia and technetium tracers: in vivo studies.肿瘤缺氧与锝示踪剂:体内研究
Curr Radiopharm. 2012 Apr;5(2):99-105. doi: 10.2174/1874471011205020099.
2
Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.缺氧诱导培养的癌细胞和小鼠异种移植瘤中示踪剂摄取的改变:对用(99m)锝-甲氧基异丁基异腈、(201)氯化铊和(99m)锝-HL91进行治疗前治疗结果预测的意义。
Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1006-11. doi: 10.1007/s00259-002-0846-x. Epub 2002 May 17.
3
Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):731-5. doi: 10.1016/s0360-3016(98)00300-9.
4
Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime).
Ann Nucl Med. 2003 Apr;17(2):131-8. doi: 10.1007/BF02988451.
5
[Biodistribution of hypoxic marker, 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime)].
Kaku Igaku. 2001 Jul;38(4):333-41.
6
Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts.
Nucl Med Commun. 2005 Dec;26(12):1067-73. doi: 10.1097/00006231-200512000-00004.
7
99mTc-HL91 "hot spot" imaging of mice bearing human carcinoma by gamma camera and the effects of tumor necrosis on imaging.
Chin Med J (Engl). 2000 May;113(5):404-7.
8
Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow.
Eur J Nucl Med. 1999 Feb;26(2):91-4. doi: 10.1007/s002590050364.
9
Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model.锝-99m HL91在肿瘤缺氧区域的积聚:体外细胞培养和体内肿瘤模型
Kaohsiung J Med Sci. 2008 Sep;24(9):461-72. doi: 10.1016/S1607-551X(09)70003-8.
10
Increased uptake of 99mTc-HL91 in tumor cells exposed to X-ray radiation.
Ann Nucl Med. 2000 Apr;14(2):139-41. doi: 10.1007/BF02988595.

引用本文的文献

1
Warm Cells, Hot Mitochondria: Achievements and Problems of Ultralocal Thermometry.暖细胞,热线粒体:超局域测温的成就与问题。
Int J Mol Sci. 2023 Nov 29;24(23):16955. doi: 10.3390/ijms242316955.
2
Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line.超越氧气极限:缺氧对一种激素非依赖性前列腺癌细胞系的影响
ISRN Oncol. 2013 Sep 12;2013:918207. doi: 10.1155/2013/918207. eCollection 2013.